BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26749901)

  • 1. [Fetal diagnosis from the mother's blood--noninvasive screening of chromosomal aberrations].
    Anttonen AK; Stefanovic V; Aittomäki K
    Duodecim; 2015; 131(22):2083-8. PubMed ID: 26749901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on current prenatal testing options: first trimester and noninvasive prenatal testing.
    Latendresse G; Deneris A
    J Midwifery Womens Health; 2015; 60(1):24-36; quiz 111. PubMed ID: 25712277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1p deletion syndrome: A prenatal diagnosis characterized by an abnormal 1st trimester combined screening test, yet a normal NIPT result.
    Yang CY; Kao CC; Chang SD; Huang SY
    Taiwan J Obstet Gynecol; 2018 Feb; 57(1):106-109. PubMed ID: 29458877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
    Shi X; Zhang Z; Cram DS; Liu C
    Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New trends in prenatal screening for chromosomal abnormalities.
    Addar MH
    Saudi Med J; 2000 May; 21(5):429-32. PubMed ID: 11500675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive prenatal testing for fetal sex determination: is ultrasound still relevant?
    Colmant C; Morin-Surroca M; Fuchs F; Fernandez H; Senat MV
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):197-204. PubMed ID: 24094458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
    Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
    Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Down syndrome screening to noninvasive prenatal testing: 20 years' experience in Taiwan.
    Shaw SW; Chen CP; Cheng PJ
    Taiwan J Obstet Gynecol; 2013 Dec; 52(4):470-4. PubMed ID: 24411028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New screen on the block: non-invasive prenatal testing for fetal chromosomal abnormalities.
    Filoche S; Lawton B; Beard A; Dowell A; Stone P
    J Prim Health Care; 2017 Dec; 9(4):248-253. PubMed ID: 29530134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester detection of double aneuploidy involving autosomes and sex chromosomes using combined biochemical and ultrasound screening.
    Spencer K
    Prenat Diagn; 2013 Nov; 33(11):1105-6. PubMed ID: 23893387
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-invasive prenatal testing is a breakthrough in prenatal screening].
    Hornstrup LS; Ambye L; Sørensen S; Jørgensen FS
    Ugeskr Laeger; 2015 Jul; 177(28):. PubMed ID: 26239855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive prenatal testing for sex chromosome abnormalities: a source of confusion.
    Kalafat E; Seval MM; Turgay B; Koç A
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25631759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential diagnostic consequences of applying non-invasive prenatal testing: population-based study from a country with existing first-trimester screening.
    Petersen OB; Vogel I; Ekelund C; Hyett J; Tabor A; ;
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):265-71. PubMed ID: 24375770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies.
    O'Leary P; Maxwell S; Murch A; Hendrie D
    Aust N Z J Obstet Gynaecol; 2013 Oct; 53(5):425-33. PubMed ID: 24090461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of "modified genetic sonography" to the combined test as a screening method for chromosomal abnormalities.
    Sainz JA; Serrano R; Turmo E; Almeida C; Caballero V; Garrido R
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1399-405. PubMed ID: 22070098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal aneuploidy detection by maternal plasma DNA sequencing: a technology assessment.
    Walsh JM; Goldberg JD
    Prenat Diagn; 2013 Jun; 33(6):514-20. PubMed ID: 23686655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Forward Look At Noninvasive Prenatal Testing.
    Liu L; Li K; Fu X; Chung C; Zhang K
    Trends Mol Med; 2016 Nov; 22(11):958-968. PubMed ID: 27726956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of two-channel sequencing-by-synthesis for noninvasive prenatal testing of fetal whole and partial chromosome aberrations.
    Neveling K; Tjwan Thung D; Beulen L; van Rens-Buijsman W; Gomes I; van den Heuvel S; Mieloo H; Derks-Prinsen I; Kater-Baats E; Faas BH
    Prenat Diagn; 2016 Mar; 36(3):216-23. PubMed ID: 26774010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and outcome of chromosomal abnormalities other than trisomy 21 in Northern Finland.
    Marttala J; Peuhkurinen S; Ranta JK; Laitinen P; Kokkonen HL; Honkasalo T; Ryynanen M
    Acta Obstet Gynecol Scand; 2011 Aug; 90(8):885-9. PubMed ID: 21539522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.